Physician profile

Samson P Samuel

Surgery of the Hand (Surgery) · Warren, MI

NPI 1679565584

$1,987.23

in general payments reported to CMS, 2019-2025

9 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$529.87
Education$20.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Pinnacle, INC $1,200.00 2022
Endo Pharmaceuticals INC. $404.46 2020-2024 Xiaflex
Integra Lifesciences Corporation $182.14 2023 Integra, Integra Dermal Regeneration Template, Primatrix
Endo USA, INC. $62.49 2024 Xiaflex
Horizon Therapeutics Plc $38.06 2022
Csl Behring $35.98 2023-2024 Kcentra
Becton, Dickinson and Company $26.18 2022
Orthofix Medical, INC. $20.22 2020-2022
Djo, LLC $17.70 2023 Cmf

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Samson P Samuel

$1,987.23

in general payments reported 2019-2025

Years
2020-2024
Top company
Pinnacle, INC

https://glasscript.com/doctor/212009/samson-p-samuel

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.